Hedgehog Signaling in Lung Cancer: From Oncogenesis to Cancer Treatment Resistance
- PMID: 30235830
- PMCID: PMC6165231
- DOI: 10.3390/ijms19092835
Hedgehog Signaling in Lung Cancer: From Oncogenesis to Cancer Treatment Resistance
Abstract
Hedgehog signaling pathway is physiologically activated during embryogenesis, especially in lung development. It is also reactivated in many solid tumors. In lung cancer, Hedgehog pathway is closely associated with cancer stem cells (CSCs). Recent works have shown that CSCs produced a full-length Sonic Hedgehog (Shh) protein, with paracrine activity and induction of tumor development. Hedgehog pathway is also involved in tumor drug resistance in lung cancer, as cytotoxic chemotherapy, radiotherapy, and targeted therapies. This review proposes to describe the activation mechanisms of Hedgehog pathway in lung cancer, the clinical implications for overcoming drug resistance, and the perspectives for further research.
Keywords: Epidermal Growth Factor Receptor (EGFR); Sonic Hedgehog; cancer stem cell; chemoresistance; immune checkpoint inhibitor; lung cancer; oncogenesis; radiotherapy; tyrosine kinase inhibitor.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


References
-
- McMahon A.P., Ingham P.W., Tabin C.J. Developmental roles and clinical significance of hedgehog signaling. Curr. Top. Dev. Biol. 2003;53:1–114. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous